• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.

作者信息

Li Y, Leung L K, Glauert H P, Spear B T

机构信息

Graduate Center for Toxicology, University of Kentucky, College of Medicine, Lexington 40536-0084, USA.

出版信息

Carcinogenesis. 1996 Nov;17(11):2305-9. doi: 10.1093/carcin/17.11.2305.

DOI:10.1093/carcin/17.11.2305
PMID:8968042
Abstract

Nuclear factor kappaB (NF-kappaB) is an important stress-induced transcription factor in many cell types, including hepatocytes. Previous studies have shown that reactive oxygen species, including hydrogen peroxide, are potent activators of NF-kappaB. Peroxisome proliferators are a group of rodent chemical carcinogens that have been proposed to act by increasing reactive oxygen in the liver. These results led us to consider whether peroxisome proliferators would increase NF-kappaB activity in the liver. Here we demonstrate that rats fed diets containing the peroxisome proliferator ciprofibrate exhibit increased hepatic NF-kappaB DNA-binding activity. This observation suggests that NF-kappaB may contribute, in part, to peroxisome proliferator-mediated changes in the liver.

摘要

相似文献

1
Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
Carcinogenesis. 1996 Nov;17(11):2305-9. doi: 10.1093/carcin/17.11.2305.
2
Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E.过氧化物酶体增殖剂环丙贝特在H4IIEC3大鼠肝癌细胞中对核因子-κB的激活作用及其被抗氧化剂N-乙酰半胱氨酸和维生素E的抑制作用。
Biochem Pharmacol. 2000 Feb 15;59(4):427-34. doi: 10.1016/s0006-2952(99)00339-1.
3
Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate.
Carcinogenesis. 1998 Apr;19(4):631-7. doi: 10.1093/carcin/19.4.631.
4
Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.地塞米松对环丙贝特诱导的细胞增殖和过氧化物酶体增殖的影响。
Fundam Appl Toxicol. 1997 Jan;35(1):78-83. doi: 10.1006/faat.1996.2264.
5
Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver.过氧化物酶体增殖剂环丙贝特和全氟癸酸对大鼠肝脏类花生酸浓度的影响。
Adv Exp Med Biol. 1997;400A:439-45. doi: 10.1007/978-1-4615-5325-0_59.
6
Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes.
Arch Pharm Res. 1998 Apr;21(2):120-7. doi: 10.1007/BF02974015.
7
Effects of vitamin E on the NF-kappaB pathway in rats treated with the peroxisome proliferator, ciprofibrate.维生素E对用过氧化物酶体增殖剂环丙贝特处理的大鼠核因子κB信号通路的影响。
Toxicol Appl Pharmacol. 2004 Aug 15;199(1):1-9. doi: 10.1016/j.taap.2004.03.006.
8
32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.体内大鼠肝脏及体外肝细胞中过氧化物酶体增殖剂-DNA加合物形成的32P后标记分析。
Carcinogenesis. 1985 Jun;6(6):933-6. doi: 10.1093/carcin/6.6.933.
9
Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes.苯巴比妥和过氧化物酶体增殖剂环丙贝特对培养大鼠肝细胞中γ-谷氨酰转肽酶活性及白三烯C4浓度的影响。
J Biochem Toxicol. 1995 Oct;10(5):239-243. doi: 10.1002/jbt.2570100503.
10
Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.环丙贝特、氯贝酸及其各自的二氟环丙基和4-氟取代类似物对大鼠的降血脂及过氧化物酶体的比较作用
Xenobiotica. 1996 Jul;26(7):695-707. doi: 10.3109/00498259609046743.

引用本文的文献

1
The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury.PPAR 在肝缺血再灌注损伤中的作用的研究现状。
PPAR Res. 2012;2012:802384. doi: 10.1155/2012/802384. Epub 2012 May 16.
2
The Role of NF-kappaB in PPARalpha-Mediated Hepatocarcinogenesis.NF-κB 在 PPARα 介导的肝癌发生中的作用。
PPAR Res. 2008;2008:286249. doi: 10.1155/2008/286249. Epub 2009 Jan 29.
3
Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.核因子-κB p50亚基在维生素E诱导的用过氧化物酶体增殖剂环丙贝特处理的小鼠变化中的作用
Food Chem Toxicol. 2008 Jun;46(6):2062-73. doi: 10.1016/j.fct.2008.01.047. Epub 2008 Feb 5.
4
The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA).小鼠甲胎蛋白启动子在肝癌细胞系HepG2中受到肝细胞核因子3(FOXA)的抑制。
DNA Cell Biol. 2002 Aug;21(8):561-9. doi: 10.1089/104454902320308933.
5
Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver.过氧化物酶体增殖物激活受体(PPAR)的药理激活对大鼠肝脏中视黄酸受体(RAR)和甲状腺激素受体(TR)表达的影响。
J Physiol Biochem. 2001 Mar;57(1):1-8.